close android install prompt
Device showcase
Download the app!
INSTALL
Johns Hopkins Guides
  • Home
  • Favorites
  • Notes
  • Prime PubMed
  • Mobile
  • Browse
PricingLog in
Refine your search:
48All Results
Johns Hopkins ABX GuideJohns Hopkins ABX Guide
Johns Hopkins HIV GuideJohns Hopkins HIV Guide
Johns Hopkins Diabetes GuideJohns Hopkins Diabetes Guide
Johns Hopkins Psychiatry GuideJohns Hopkins Psychiatry Guide
Medical NewsMedical News
Johns Hopkins Author BiosJohns Hopkins Author Bios
Message Center - Hopkins GuidesMessage Center - Hopkins Guides
Oritavancin
48 results
1 - 48
  • Johns Hopkins ABX GuideOritavancin
    • INDICATIONS
      • FDA
    • COMMENTS
    • FORMS
    • References
    • USUAL ADULT DOSING
    • ADULT RENAL DOSING
      • DOSING IN HEMODIALYSIS
      • DOSING IN PERITONEAL DIALYSIS
      • DOSING IN RENAL REPLACEMENT THERAPY
      • Other Adult Renal Dosing
    • PEDIATRIC DOSING
      • USUAL PEDIATRIC DOSING
    • ADVERSE DRUG REACTIONS
      • GENERAL
      • OCCASIONAL
      • RARE
    • DRUG INTERACTIONS
    • SPECTRUM
    • RESISTANCE
    • PHARMACOLOGY
      • MECHANISM
      • PHARMACOKINETIC PARAMETERS
        • Absorption
        • Metabolism and Excretion
        • Protein Binding
        • Cmax, Cmin, and AUC
        • T1/2
        • Distribution
      • DOSING FOR DECREASED HEPATIC FUNCTION
      • PREGNANCY RISK
      • BREAST FEEDING COMPATIBILITY
  • Johns Hopkins ABX GuideCellulitis
    • Pathogen Specific Therapy
  • Johns Hopkins ABX GuideFuruncle/Carbuncle
    • TREATMENT
      • Systemic Therapy, Adult
    • Basis for recommendation
  • Johns Hopkins ABX GuideEnterococcus
    • TREATMENT
      • Endocarditis
      • VRE
      • Selected Drug Comments
    • References
  • Johns Hopkins ABX GuideTelavancin
    • References
  • Johns Hopkins ABX GuideAnthrax, Pre-exposure and Post-Exposure Prevention
    • CLINICAL
  • Johns Hopkins ABX GuideVascular Catheter-Associated Infection
    • TREATMENT
      • Selected Drug Comments
  • Johns Hopkins ABX GuideStaphylococci, coagulase negative
    • TREATMENT
      • General principles for CoNS infections
  • Johns Hopkins ABX GuideSurgical Site Infections (SSI)
    • TREATMENT
      • Surgical site infections or dirty wound coverage
    • References
  • Johns Hopkins ABX GuideStaphylococcus aureus
    • TREATMENT
      • Selected Drug Comments
      • Soft tissue infections
  • Johns Hopkins ABX GuideDalbavancin
    • References
  • 1 - 48 of 48 records
Your free 1 year of online access expired  .

Want to regain access to Johns Hopkins Guides?

Log in to Johns Hopkins Guides

Note: Your username may be different from the email address used to register your account.

Contact Support

If you need further assistance, please contact Support.
  • unboundmedicine.com/support
  • support@unboundmedicine.com
  • 610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)
Password reset sent
Username sent
Forgot your username or password?
Purchase Johns Hopkins Guides
New to Johns Hopkins Guides?
Purchase a subscription
A Johns Hopkins Guides subscription is required to
Already have an account?Log In
Purchase Johns Hopkins Guides
New to Johns Hopkins Guides?
Purchase a subscription
Unbound Medicine logo
  • Home
  • Contact Us
  • Privacy / Disclaimer
  • Terms of Service
  • Log in

© 2000–2025 Unbound Medicine, Inc. All rights reserved

CONNECT WITH US

facebookinstagramyoutubeLinkedIn

25.09.04-25.09.04_04